Faculty of Law, University of Technology Sydney, PO Box 123, Broadway, Sydney, NSW, 2007, Australia.
Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
J Bioeth Inq. 2019 Sep;16(3):415-429. doi: 10.1007/s11673-019-09929-x. Epub 2019 Jul 11.
People with dementia have commonly been excluded from research. The adverse impacts of this exclusion are now being recognized and research literature, position statements, and ethics guidelines increasingly call for inclusion of people with dementia in research. However, few published studies investigate the views of potential participants on taking part in research should they experience dementia-related cognitive impairment. This cross-sectional survey examined the views of people aged sixty and older (n=174) attending hospital outpatient clinics about clinical research participation if they had dementia and impaired decision-making ability. Over 90 percent of respondents were agreeable to participating in a wide range of research activities, such as cognitive testing, physical measurements, imaging procedures, and blood draws. For drug studies, however, agreement dropped to 60 percent. Altruism was a strong motivator for research participation. In regard to who should be involved in decisions about their participation in research during periods of incapacity, respondents mostly preferred the person they appoint as their substitute decision-maker for healthcare matters (88%) or a doctor or health professional on the research team (78%). Over three-quarters (79%) expressed interest in making an advance research directive. The study findings are discussed in relation to law reforms in Australia that aim to strengthen respect and inclusion for people with impaired decision-making capacity, especially by providing frameworks for advance planning for research participation.
痴呆症患者通常被排除在研究之外。这种排斥的负面影响现在正在被认识到,研究文献、立场声明和伦理准则越来越多地呼吁将痴呆症患者纳入研究。然而,很少有已发表的研究调查潜在参与者在出现与痴呆相关的认知障碍时对参与研究的看法。这项横断面调查研究了 174 名年龄在 60 岁及以上、在医院门诊就诊的人的看法,如果他们患有痴呆症且决策能力受损,他们是否愿意参与临床研究。超过 90%的受访者同意参与广泛的研究活动,如认知测试、身体测量、成像程序和血液采集。然而,对于药物研究,同意率降至 60%。利他主义是参与研究的一个强有力的动机。关于在无能力期间谁应该参与他们参与研究的决策,受访者大多更倾向于他们指定的替代医疗决策人(88%)或研究团队中的医生或健康专业人员(78%)。超过四分之三(79%)的人表示有兴趣制定预先的研究指示。研究结果与澳大利亚的法律改革有关,这些改革旨在加强对决策能力受损者的尊重和包容,特别是通过为研究参与提供预先规划的框架。